Search research articles
Contact Us
Filters
Showing results (201-210 of 228) with videos related to
Page
of 23
Sort By:
Gynecologic Oncology
|
January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Mihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Human Gene Therapy
|
May 26, 2019
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy
Yuefeng Yang, Weidong Xu, Di Peng, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 28, 2022
Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study
Chalinee Monsereenusorn, Ana Patricia Alcasabas, Amos Hong Pheng Loh, et al.
Nursing Research
|
September 3, 2013
Reproductive health choices for young adults with sickle cell disease or trait: randomized controlled trial immediate posttest effects
Diana J Wilkie, Agatha M Gallo, Yingwei Yao, et al.
Kidney Medicine
|
August 6, 2024
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
Bradley P Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, et al.
Annals of Surgical Oncology
|
October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I Trial
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Frontiers in Oncology
|
August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Gastroenterology
|
June 14, 2011
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times
Khairuddin Memon, Laura Kulik, Robert J Lewandowski, et al.
Annals of Surgical Oncology
|
October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2012
Aurora B kinase phosphorylates and instigates degradation of p53
Chris P Gully, Guermarie Velazquez-Torres, Ji-Hyun Shin, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 228) with videos related to
Sort By:
Page
of 23
Gynecologic Oncology
|
January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Mihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
Human Gene Therapy
|
May 26, 2019
An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy
Yuefeng Yang, Weidong Xu, Di Peng, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 28, 2022
Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study
Chalinee Monsereenusorn, Ana Patricia Alcasabas, Amos Hong Pheng Loh, et al.
Nursing Research
|
September 3, 2013
Reproductive health choices for young adults with sickle cell disease or trait: randomized controlled trial immediate posttest effects
Diana J Wilkie, Agatha M Gallo, Yingwei Yao, et al.
Kidney Medicine
|
August 6, 2024
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials
Bradley P Dixon, David Kavanagh, Alvaro Domingo Madrid Aris, et al.
Annals of Surgical Oncology
|
October 29, 2025
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter U.S. Phase I Trial
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Frontiers in Oncology
|
August 16, 2024
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Gastroenterology
|
June 14, 2011
Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times
Khairuddin Memon, Laura Kulik, Robert J Lewandowski, et al.
Annals of Surgical Oncology
|
October 1, 2025
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial
Brad Nakamura, Rosemary Senguttuvan, Nora H Ruel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2012
Aurora B kinase phosphorylates and instigates degradation of p53
Chris P Gully, Guermarie Velazquez-Torres, Ji-Hyun Shin, et al.
Page
of 23